Many biotech stocks have performed well this year so far and one of those is that of Fortress Biotech (NASDAQ: FBIO), which has generated notable gains.
The Fortress stock has gone up by as high as 35% so far this year and in light of such gains, it might be a good idea for investors to look into the company a bit more closely. The company runs a sprawling business and is working on treatments for a wide range of conditions. Most of its projects have the potential for considerable growth since the demand is unmet.
In addition to that, investors should also note that Fortress Biotech’s operations are managed through a string of subsidiaries. Many of them have managed to strike up important partnerships and that is another factor that needs to be considered when weighing up the Fortress stock. It remains to be seen if the stock can continue to grow as investor interest rises.